Xeomin 100 unit vials
Ended Awarded Last action
- Contract number
- SPE2DR26F3P4P
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,101
Award facts
- Contract value 100% obligated
- $2,101.19 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $2,101.19 to AmerisourceBergen Drug Corp for the supply of Xeomin 100 Unit Vials. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is scheduled for completion by February 4, 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement needs across military and veteran healthcare systems. The company operates as a subsidiary of Cencora, Inc., which does business as AmerisourceBergen and maintains significant federal contracting relationships across multiple therapeutic domains.
This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with the DLA Troop Support Medical (designated SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 through December 2026. The IDC enables the contractor to supply a vast range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and medical devices. Through this structure, AmerisourceBergen serves customers including the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems, with this particular order for Xeomin representing a specialized neurological treatment procurement supporting federal medical operations.
Quick answers
Who was awarded contract SPE2DR26F3P4P?
SPE2DR26F3P4P was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 13, 2026.
How much is contract SPE2DR26F3P4P worth?
The government has obligated $2,101 on SPE2DR26F3P4P.
Is contract SPE2DR26F3P4P an order under another contract?
Yes. SPE2DR26F3P4P is a delivery order under SPE2DR25D3008, an indefinite delivery contract.
Was contract SPE2DR26F3P4P competed?
The extent of competition for SPE2DR26F3P4P was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award